Tamiflu approved for use in children

The antiviral agent Tamiflu (oseltamivir) has been approved for the prevention of influenza in children aged one year and over.

Previously, Tamiflu was licensed only for the treatment of influenza in children of this age, and for the treatment and prophylaxis of influenza in adults.

The dose of Tamiflu for prophylaxis in children is based on the child's body-weight. The recommended dose is 30mg once daily for children weighing less than 15 kg, 45 mg once daily for those weighing 15 to 23 kg, 60 mg once daily for those weighing 23 to 40 kg, and 75 mg once daily for those weighing more than 40 kg.

The duration of prophylactic treatment for all patients, children and adults, has been extended from 7 days to 10 days. Dosing should begin as soon as possible within two days of exposure to an infected person.

Further information: Roche Products Ltd, Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire AL7 1TW. Tel: (01707) 366000.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases